Biocon Share price target & analyst calls

₹330.3-4.70 (-1.40%)

Avg 1-year target

10 of 12 long-term calls BUY

₹485.1346.9% above today's price

Biocon's average 1-year share price target is ₹485.13, the average of 8 advisors' latest targets. Targets range from ₹320 to ₹750.

Latest: Nuvama Wealth ₹520 · 7 Aug 2026

15
12 BUY · 3 SELL, all horizons
8
with an active 1Y target
37%
18 of 49 closed calls hit
68
all horizons, open and closed

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Biocon target price by brokerage

Each advisor's latest 1-year target · 8 advisors · tap a row for the call

All tips (68)

BUYTarget₹520
NWbyNuvama Wealth+57.4% to target
1 Year* · 10 mo left · 7 Aug 2026 · entry ₹430 · via ET Now (Live)P&L -23.2%
BUYTarget₹520
MObyMotilal Oswal+57.4% to target
1 Year* · 10 mo left · 6 Aug 2026 · entry ₹436.6 · via Institutional / Brokerage ResearchP&L -24.3%
SELLTarget₹326
BbyBernstein+1.3% to target
1 Year* · 9 mo left · 15 Jul 2026 · entry ₹438 · via CNBC Awaaz.P&L +24.6%
BUYTarget₹495
DCbyDAM Capital+49.9% to target
1 Year* · 9 mo left · 15 Jul 2026 · entry ₹438 · via CNBC Awaaz.P&L -24.6%
BUYTarget₹500
1 Year · 9 mo left · 10 Jul 2026 · entry ₹411.55 · via CNBC Awaaz.P&L -19.7%
BUYTarget₹750
1 Year* · 8 mo left · 1 Jul 2026 · entry ₹417.95 · via Business TodayP&L -21.0%
BUYTarget₹700
1 Year* · 7 mo left · 20 May 2026 · entry ₹432.55 · via Business TodayP&L -23.6%
BUYTarget₹450
MObyMotilal Oswal+36.2% to target
1 Year* · 4 mo left · 13 Feb 2026 · entry ₹377.95 · via Institutional / Brokerage ResearchP&L -12.6%
BUYTarget₹460
MObyMotilal Oswal+39.3% to target
1 Year* · 7 wk left · 8 Dec 2025 · entry ₹383.8 · via Institutional / Brokerage ResearchP&L -13.9%
SELLTarget₹320
ISbyICICI Securities+3.1% to target
1 Year* · 3 wk left · 14 Nov 2025 · entry ₹411.15 · via Institutional / Brokerage ResearchP&L +19.7%
BUYTarget₹450
ASbyAxis Securities+36.2% to target
1 Year* · 3 wk left · 13 Nov 2025 · entry ₹417 · via Institutional / Brokerage ResearchP&L -20.8%
BUYTarget₹480
MObyMotilal Oswal+45.3% to target
1 Year* · 3 wk left · 12 Nov 2025 · entry ₹405.9 · via Institutional / Brokerage ResearchP&L -18.6%
BUYTarget₹435
1 Year* · 16 Feb 2026 · entry ₹380.35 · via Institutional / Brokerage Researchexit ₹435
SELLTarget₹350
1 Year* · 10 Dec 2025 · entry ₹379.15 · via Institutional / Brokerage Researchexit ₹350
BUYTarget₹440
1 Year* · 29 Nov 2025 · entry ₹394.5 · via Institutional / Brokerage Researchexit ₹440
BUYTarget₹380
1 Year* · 11 Aug 2025 · entry ₹342.1 · via Institutional / Brokerage Researchexit ₹380
BUYTarget₹410
1 Year* · 8 Aug 2025 · entry ₹343.35 · via Institutional / Brokerage Researchexit ₹410
BUYTarget₹351
1 Year* · 3 May 2025 · entry ₹335.9 · via Institutional / Brokerage Researchexit ₹351
BUYTarget₹405
1 Year* · 1 Feb 2025 · entry ₹370.45 · via Institutional / Brokerage Researchexit ₹405
BUYTarget₹370
1 Year* · 31 Oct 2024 · entry ₹316.1 · via Institutional / Brokerage Researchexit ₹370
BUYTarget₹390
1 Year* · 5 Aug 2024 · entry ₹340.4 · via Institutional / Brokerage Researchexit ₹390
BUYTarget₹400
1 Year* · 28 Jun 2024 · entry ₹351.1 · via Institutional / Brokerage Researchexit ₹400
BUYTarget₹340
1 Year* · 17 May 2024 · entry ₹305.85 · via Institutional / Brokerage Researchexit ₹340
BUYTarget₹332
1 Year* · 17 Jan 2024 · entry ₹280.3 · via Institutional / Brokerage Researchexit ₹332
SELLTarget₹312
1 Year* · 3 Oct 2025 · entry ₹352.25 · via Institutional / Brokerage Researchexit ₹370.7
SELLTarget₹270
1 Year* · 9 Aug 2025 · entry ₹343.35 · via Institutional / Brokerage Researchexit ₹426.35
BUYTarget₹430
1 Year* · 13 Jan 2025 · entry ₹365.2 · via Institutional / Brokerage Researchexit ₹377.3
SELLTarget₹335
RSbyRajesh Satpute⏳ Pending entry
1–3 Months · 3 mo left · 9 Oct 2026 · entry ₹360 · via CNBC Awaaz.
BUYTarget₹424
ASbyAxis Securities+28.4% to target
1–3 Months* · 8 wk left · 19 Sept 2026 · entry ₹385 · via Economic Times New Stock RecosP&L -14.2%
BUYTarget₹435
1–3 Months · 5 Aug 2026 · entry ₹426 · via Zee Business (Live)exit ₹435
BUYTarget₹420
1–3 Months* · 11 May 2026 · entry ₹400 · via ET Nowexit ₹420
BUYTarget₹500
1–3 Months* · 17 Aug 2026 · entry ₹410.3 · via Zee Business (Live)exit ₹395
BUYTarget₹466
1–3 Months · 24 Jul 2026 · entry ₹435.2 · via LiveMint Marketsexit ₹420
BUYTarget₹480
1–3 Months · 15 Jul 2026 · entry ₹405 · via Business Todayexit ₹380
BUYTarget₹463
ICbyIDBI CapitalStop-loss hit
1–3 Months · 23 Jun 2026 · entry ₹428 · via IDBI Capital Research Calls Telegramexit ₹412
BUYTarget₹550
1–3 Months · 15 Jul 2026 · entry ₹410 · via CNBC Awaaz.exit ₹352
BUYTarget₹345
KBbyKunal Bothra+4.5% to target
1–2 Weeks* · 13d left · 22 Oct 2026 · entry ₹330.25 · via ET Now (Live)P&L +0.0%
BUYTarget₹390
1–2 Weeks* · 17 Sept 2026 · entry ₹376.3 · via CNBC Awaaz.exit ₹390
BUYTarget₹425
1–2 Weeks* · 19 Jun 2026 · entry ₹417.15 · via CNBC Awaaz.exit ₹425
BUYTarget₹440
1–2 Weeks* · 19 May 2026 · entry ₹428.15 · via Business Todayexit ₹440
BUYTarget₹390
1–2 Weeks* · 5 May 2026 · entry ₹368.25 · via ET Nowexit ₹390
BUYTarget₹440
1–2 Weeks* · 27 Aug 2026 · entry ₹417.55 · via Zee Business (Live)exit ₹408
BUYTarget₹442
1–2 Weeks* · 26 Aug 2026 · entry ₹418.7 · via CNBC Awaaz.exit ₹408
BUYTarget₹435
1–2 Weeks* · 18 Aug 2026 · entry ₹419.5 · via CNBC Awaaz.exit ₹412
BUYTarget₹448
SRbySahi ResearchStop-loss hit
1–2 Weeks* · 12 Aug 2026 · entry ₹428 · via Sahi Research Telegramexit ₹418
BUYTarget₹468
1–2 Weeks* · 7 Aug 2026 · entry ₹437 · via LiveMint Buy-or-Sell (topic)exit ₹421
BUYTarget₹458
PRbyPankaj RandadStop-loss hit
1–2 Weeks* · 6 Aug 2026 · entry ₹434 · via CNBC Awaaz.exit ₹420
BUYTarget₹450
SRbySahi ResearchStop-loss hit
1–2 Weeks* · 6 Aug 2026 · entry ₹432 · via Sahi Research Telegramexit ₹420
BUYTarget₹460
1–2 Weeks* · 27 Jul 2026 · entry ₹435.8 · via CNBC Awaaz.exit ₹426
BUYTarget₹485
1–2 Weeks* · 6 Jul 2026 · entry ₹426.8 · via NDTV Profit (Live)exit ₹399

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Full call history, all horizons: page 2 of 2

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks